Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis

Background & aimsThe effectiveness of adjuvant immunotherapy to diminish recurrence and improve long-term prognosis following curative-intent surgical resection for hepatocellular carcinoma (HCC) is of increased interest, especially among individuals at high risk of recurrence. The objective of...

Descripción completa

Detalles Bibliográficos

Autores principales:	Xiao Xu, Ming-Da Wang, Jia-Hao Xu, Zhong-Qi Fan, Yong-Kang Diao, Zhong Chen, Hang-Dong Jia, Fu-Bao Liu, Yong-Yi Zeng, Xian-Ming Wang, Han Wu, Wei Qiu, Chao Li, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2024-01-01
Colección:	Frontiers in Immunology
Materias:	hepatocellular carcinoma BCLC staging recurrence adjuvant therapy immune checkpoint inhibitors propensity matching analysis
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1322233/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!